Pharmaceutical manufacturers and the US Food and Drug Administration (FDA) agree that finding ways to improve the process of drug testing to make it faster while still ensuring medication safety and efficacy is a worthy goal. Some researchers are suggesting that changes in how trial data are assessed may help streamline this process.
Some researchers argue that intent-to-treat analysis for assessing drug trial data may introduce biases that obscure the true efficacy or safety of a medication.
Graphic Jump Location
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.